Fujifilm Diosynth Expands R&D Capabilities

Fujifilm Diosynth Biotechnologies has completed the first phase of $4.5 million investment in new equipment and labs at its Billingham, UK site. This expansion includes a complete refurbishment of its microbial fermentation lab, including eight new sterilizable 20L Sartorius Stedim Biotech fermenters, and several DASGIP parallel bench-top high throughput units.

Also, a new suite of R&D labs has been installed for process development work, with a corresponding increase in the company’s R&D workforce to more than 150. The company plans to add more employees during the coming year at both its Billingham and NC sites.

Mark Carver, Ph.D., senior vice president Research, Development & Innovation, said, “This investment is in response to our growing innovation activity and to increasing demand from customers for our expertise fast-track development of cost-effective processes for the manufacture of biologics. We are committed to continue to develop leading technology which will deliver benefits to our customers and their patients.”